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ABSTRACT 
The cardiac neural crest originates in the caudal hindbrain, migrates to the heart, and 
contributes to septation of the cardiac outflow tract and ventricles, an ability unique to this neural 
crest subpopulation. Here we have used a FoxD3 neural crest enhancer to isolate a pure 
population of cardiac neural crest cells for transcriptome analysis. This has led to the identification 
of transcription factors, signaling receptors/ligands, and cell adhesion molecules upregulated in 
the early migrating cardiac neural crest. We then functionally tested the role of one of the 
upregulated transcription factors, MafB, and found that it functions as a regulator of Sox10 
expression specifically in the cardiac neural crest. Our results not only reveal the genome-wide 
profile of early migrating cardiac neural crest cells, but also provide molecular insight into what 
makes the cardiac neural crest unique. 
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INTRODUCTION 
The neural crest is an embryonic cell population, characterized by broad migratory and 
differentiation ability. Arising within the central nervous system shortly after neural tube closure, 
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neural crest cells undergo an epithelial to mesenchymal transition and begin migrating along 
stereotypic pathways to diverse sites throughout the body. Upon cessation of migration, they 
differentiate into numerous derivatives including elements of the craniofacial skeleton, peripheral 
nervous system, connective tissue and melanocytes. Just as the nervous system is patterned 
along the body axis, neural crest cells have different developmental capabilities depending upon 
their site of origin within the neural tube. For example, only cranial neural crest cells contribute to 
bone and cartilage of the face whereas neural crest cells emerging at spinal cord levels fail to do 
so (Le Douarin, 1982; Simoes-Costa and Bronner, 2016). 
Arising in the dorsal neural tube just caudal to the cranial region is the “cardiac” neural 
crest, a particularly interesting region which is the only neural crest population that contributes to 
the cardiovascular system. Based on fate mapping studies using quail-chick chimeras, the 
cardiac neural crest has been shown to originate in the neural tube from the middle of the otic 
vesicle to the 3rd somite, corresponding to rhombomeres 6, 7 and 8 (Hutson and Kirby, 2007; 
Kirby et al., 1985). From this site of origin, these cells migrate through pharyngeal arches 3, 4 and 
6 to contribute to elements of the cardiovascular system, including the aortic arch arteries and 
septum of the outflow tract into aortic and pulmonary trunks (Kirby et al., 1983; Le Lièvre and Le 
Douarin, 1975). They also contribute to the valves, ventricular septae and the cardiac ganglion 
(Kirby and Stewart, 1983; Waldo et al., 1998). 
Surgical ablation of the cardiac neural crest cell population results in a severe heart defect 
known as persistent truncus arteriosus (Besson et al., 1986; Kirby et al., 1985; Nishibatake et al., 
1987). This is caused by the absence of truncal and aorticopulmonary septa, resulting in fusion of 
the pulmonary and aortic blood vessels. Congenital heart defects, including failure in septation or 
abnormalities of the great arteries, are the most common human birth defects observed in the 
general population (Neeb et al., 2013). Importantly, other neural crest populations are unable to 
rescue the effects of cardiac crest ablation, even when grafted in its place at stage HH10 (Kirby, 
1989). Thus, the unique developmental potential of the cardiac neural crest to contribute to the 
cardiovascular system, that is lacking in other neural crest populations, seems to be determined 
at early developmental stages. 
  
Neural crest cell formation is guided by a gene regulatory network (GRN) comprised of a 
combination of transcription factors and signaling molecules (Meulemans and Bronner-Fraser, 
2004; Simões-Costa and Bronner, 2015). One means of demonstrating direct connections within 
this GRN has been to identify enhancers and their inputs for neural crest genes like Sox10 and 
FoxD3 (Betancur et al., 2010; Simões-Costa et al., 2012). These have been best characterized 
for the cranial neural crest. However, the gene regulatory circuit that imbues the cardiac neural 
crest with its singular abilities remains a mystery. 
To understand the molecular mechanisms that render the cardiac neural crest unique, we 
sought to identify transcription factors and other genes highly upregulated in this cell population 
and determine their regulatory relationships. To this end, in the present study, we have used a 
FoxD3 neural crest enhancer that drives expression of GFP in the neural crest to isolate a pure 
population of early migrating cardiac neural crest cells for transcriptional profiling. This has led to 
the identification of transcription factors, signaling receptors and ligands, as well as cell adhesion 
molecules amongst other genes that are upregulated in the early migrating cardiac neural crest. 
We then functionally tested the role of the transcription factor MafB in the cardiac neural crest. 
MafB knockdown affects the cardiac neural crest stream and causes reduction in expression of 
Sox10, Krox20 and MafB itself. Furthermore, MafB appears to regulate expression of a Sox10 
enhancer in the cardiac neural crest. Taken together, the results reveal a novel role for MafB in 
cardiac neural crest cells. 
 
RESULTS 
FoxD3 NC2:EGFP reporter enables isolation of a pure population of cardiac neural crest 
cells for transcriptome profiling 
FoxD3 is a neural crest specifier gene expressed in the pre-migratory and early migrating 
neural crest. The FoxD3 enhancer NC2 drives expression in neural crest cells emerging posterior 
to rhombomere 4 (Simões-Costa et al., 2012). Therefore, we took advantage of this enhancer to 
drive GFP expression in cardiac neural crest cells. To this end, we electroporated the NC2:EGFP 
  
construct into Hamburger and Hamilton (HH) stage 4 chicken embryos and incubated them until 
HH12, by which time cardiac neural crest migration had initiated (Fig. 1A,B). To confirm neural 
crest identity of the GFP-expressing cells, we performed immunostaining with HNK-1 and 
anti-GFP antibodies on transverse sections posterior to the otic vesicle. The results showed that 
the majority of HNK-1+ cells expressed GFP, which was only present in HNK-1+ cells with the 
exception of pre-migratory neural crest cells still associated with the dorsal neural tube (Fig. 1C).  
With an eye toward identifying transcription factors and signaling molecules upregulated 
in the cardiac neural crest, we performed transcriptome analysis of this cell population. Because 
the NC2 enhancer also drives expression further caudally in the trunk, we dissected the 
embryonic region posterior to the otic vesicle to the 3rd somite (Fig. 1B), dissociated the tissue 
and sorted GFP-positive cells to obtain a population of pure migrating cardiac neural crest cells 
(Fig. 1D). RNA was extracted, reverse transcribed and amplified for library preparation and 
sequencing. We compared the RNA-seq data from cardiac neural crest cells with the 
GFP-negative cell population from the same embryonic region. The results revealed a list of 677 
genes (Supplemental Table 1) that are enriched and 721 (Supplemental Table 2) that are 
depleted in early migrating cardiac neural crest cells, compared with the GFP-negative population 
(Fig. 1E).  
To identify gene sets specifically enriched in cardiac neural crest cell and/or shared with 
other neural crest population, we compared the lists of genes upregulated in the cardiac and the 
cranial population, the latter from previous studies (Simões-Costa et al., 2014). Comparative 
analysis revealed that, amongst the list of genes upregulated in either of these neural crest 
populations, 570 genes are specifically enriched in the cardiac crest, 1074 genes unique to the 
cranial neural crest cells, and 107 genes shared by both populations (Fig. 1F). Of these, 30 
transcriptional regulators were specific to the cardiac cells, 82 specific to the cranial, and 17 
shared by both populations (Fig. 1F). Protein classification of the cardiac-enriched genes 
revealed a high frequency of nucleic acid binding, enzymatic and transcription factor activity in the 
encoded proteins (Fig. 1H). Functional annotation clustering revealed enrichment of terms related 
to translation and RNA processing, suggesting that post-transcriptional regulation is an important 
  
aspect of the biology of migrating cardiac neural crest cells. The presence of genes related to 
cardiomyopathies highlights the essential contribution of these cells to heart development (Fig. 
1I). In particular, this analysis revealed 34 transcription factors, 14 signaling molecules, 18 
receptors, and 6 cell adhesion molecules upregulated in the early migrating cardiac neural crest. 
Identification of novel players in migrating cardiac neural crest cells 
To validate the gene set enriched in our transcriptome analysis of cardiac neural crest 
relative to surrounding tissues, we performed whole mount in situ hybridization on embryos at 
early stages of cardiac neural crest migration (HH12/13), focusing on transcription factors and 
signaling molecules. 14 of 20 genes tested showed expression in the cardiac neural crest streams 
(Fig. 2 and Supplemental Fig. 1). These included known neural crest factors, such as CXCR4, 
Ret, Snail2, Sox10, as well as novel players, such as Dlx5 and Nrip1, whose expression was not 
previously associated with the cardiac neural crest (Fig. 2). Transverse sections caudal to the otic 
vesicle and immunostaining with HNK-1 confirmed cardiac neural crest expression 
(Supplemental Fig. 1). 
The transcription factor MafB, previously best known for its expression and function in 
rhombomeres 5 and 6, was amongst the highest upregulated genes in the cardiac neural crest 
(Fig. 1G). Consistent with previous reports (Eichmann et al., 1997; Lecoin et al., 2004), we first 
observed MafB expression in rhombomeres 5 and 6 at stage HH10 and expression was 
maintained not only in the rhombomeres, but also in cardiac neural crest cells at stage HH13 (Fig. 
2A and Supplemental Fig. 2A,B). Neural crest expression was confirmed in transverse sections 
immediately caudal to the otic vesicle (Supplemental Fig. 2C). We further confirmed the identity of 
MafB-positive cells in the rhombomeres and cardiac neural crest using double fluorescence in situ 
hybridization of MafB and Krox20 (also known as Egr2), another gene selectively expressed in 
the hindbrain and the associated neural crest cells (Schneider-Maunoury et al., 1993). MafB and 
Krox20 are expressed in rhombomeres 5/6 and rhombomeres 3/5, respectively, and our results 
clearly show that expression of the two transcription factors overlaps in the cardiac neural crest 
stream emanating from rhombomere 5 (Fig. 2B). 
  
Loss of MafB reduces the cardiac neural crest stream 
As MafB function was not previously reported in the cardiac neural crest, we next sought 
to examine its role by using a FITC-tagged translation-blocking morpholino (MO) for 
loss-of-function experiments (Fig. 3A). To demonstrate MO efficacy, we compared the ability of 
MafB versus control MO to block expression of a construct containing the truncated 5’ UTR and 
CDS of MafB, including the MO recognition sequence, driving expression of RFP (Supplemental 
Fig. 3A). Control MO was electroporated onto one side of the embryo and MafB MO onto the 
contralateral side (Supplemental Fig. 3B). The results show that the translation blocking MO 
eliminates reporter expression whereas control MO has no effect (Supplemental Fig. 3C-E). 
To test the effects of MafB loss on cardiac neural crest development, we electroporated 
the translation-blocking MOs into the right side of HH4 chick embryos, using the left side as an 
internal control (Fig. 3B). Electroporated embryos were incubated until stage HH12, fixed and 
immunostained with the HNK-1 antibody to detect migrating neural crest cells. To allow 
comparison of phenotypes from control and MafB-depleted embryos, these were classified 
according to the severity and grouped as severe, strong, mild or none (Supplemental Fig. 4A). 
After MafB knockdown, HNK-1 signal was greatly reduced in cardiac neural crest cells when 
compared to either non-transfected contralateral controls or embryos electroporated with a 
control MO, whereas the cranial neural crest was unaffected (Fig. 3C-F and Supplemental Fig. 
4B). As a second means of performing MafB knockdown, we created two dominant negative 
constructs: one in which the N-terminal acidic domain that functions for transactivation (1-194 
amino acid) was removed (MafBN) and a second composed of MafBN fused to the Engrailed 
repressor domain (EnR; Conlon et al., 1996) (MafBN-EnR; Fig. 3A and Supplemental Fig. 4B). 
In both expression vectors, a CAG promoter drives expression of a bicistronic transcript 
containing an internal ribosomal entry site (IRES) and mRFP fused to Histone H2B 
(pCI-IRES-H2B-RFP; Williams et al., 2018). These constructs were electroporated onto the right 
side of HH4 embryos. Transfected embryos that efficiently expressed H2B-RFP were identified 
and immunostained with HNK-1 antibody for phenotype analysis. The results revealed a 
reduction of HNK-1-positive cells in the cardiac stream similar to that seen with MafB MO (Fig. 
  
3I-L and Supplemental Fig. 4B), whereas electroporation of the reporter alone produced no 
phenotype (Fig. 3G-H). Taken together, these results indicate that MafB is required for proper 
cardiac neural crest development. 
Effects of MafB loss on other cardiac neural crest genes  
To examine the role of MafB in the cardiac neural crest gene regulatory network, we 
examined the effects of MafB knockdown on expression of other neural crest transcription factors. 
To this end, embryos were electroporated with MafB or control MO on the right side and allowed 
to develop until stage HH12 prior to in situ hybridization with the neural crest markers Sox10, 
Krox20, Ets1 as well as MafB itself. Embryos electroporated with control MO showed no or few 
differences between right and left sides (Fig. 4B,E,H,K and Supplemental Fig. 4B). In contrast, 
expression of Sox10 was reduced in the cardiac crest stream on the knockdown side of embryos 
treated with MafB MO, whereas cranial neural crest cells were unaffected (Fig. 4C and 
Supplemental Fig. 4). Expression of Krox20, Ets1 and MafB itself was also reduced (Fig. 4F,I,L 
and Supplemental Fig. 4B). Similarly, embryos transfected with MafB dominant negative 
constructs exhibited similar loss of Sox10, Krox20 and MafB on the knockdown side, whereas 
embryos electroporated with the empty vector showed no effect (Supplemental Figs. 4B and 5). 
Cumulatively, these results show that MafB is important for gene expression in the early migrating 
cardiac neural crest.  
Given the advent of CRISPR-Cas9 technology for loss of function analysis, we used 
CRISPR-Cas9 plasmid constructs previously optimized for electroporation in chicken embryos 
(Gandhi et al., 2017) to induce mutations in the MafB locus. For this purpose, we designed two 
guide RNAs (gRNAs), one targeting the start codon of MafB, and the second targeting an internal 
region of its first exon (Fig. 4A). Constructs bearing MafB gRNAs and Cas9 were 
co-electroporated into the right side of stage HH4 embryos while control gRNA and Cas9 were 
co-electroporated on the left side of the same embryo. We then examined the effects of genome 
editing of MafB locus on the expression of aforementioned neural crest genes. Analogous to the 
phenotype observed with the MafB MO, expression of all genes tested was reduced in migrating 
  
cardiac neural crest cells on the knockout side, when compared to the contralateral internal 
control (Fig. 4D,G,J,M). In contrast, CRISPR-mediated loss of MafB caused no effect on the 
FoxD3 NC2 enhancer, suggesting a requirement during migration but not induction of the cardiac 
NC population (Supplemental Fig. 6). 
MafB is critical for Sox10E2 enhancer activity in the cardiac neural crest  
Sox10 is a neural crest marker gene expressed at all axial levels including the cardiac 
neural crest. The Sox10E2 enhancer is specifically expressed in the cranial plus post-otic neural 
crest, but absent from the trunk neural crest (Betancur et al., 2010). To verify expression driven by 
this enhancer in the cardiac neural crest, we electroporated Sox10E2:EGFP reporter into HH4 
chick embryos. Reporter expression was observed in the cardiac neural crest stream at HH12 
(Fig. 5B), indicating that cardiac neural crest cells express inputs for Sox10E2 activity. 
Previous work has shown that Ets1, cMyb and Sox9 are direct activators of this enhancer 
at cranial levels (Betancur et al., 2010). To test whether MafB is an input for Sox10E2 enhancer 
activity in the cardiac neural crest, we used double-sided electroporations, in which 
Sox10E2:GFP was injected on both sides and control reagents were injected onto the left side of 
the embryo, to examine the effects of MafB dominant negative constructs and CRISPR-mediated 
loss of MafB on the ability of the enhancer to drive reporter expression (Fig. 5A). For the latter, 
plasmids driving ubiquitous expression of Cas9, gRNAs and H2B-RFP reporter were 
co-electroporated. In both cases, loss of MafB caused a marked reduction in reporter expression 
compared with control side, suggesting requirement for Sox10E2 activity in the cardiac neural 
crest stream (Fig. 5C,D). 
The transcription factors Sox10, Ets1, MafB and Krox20 are concomitantly expressed in 
migrating cardiac neural crest cells (Fig. 6A-D), whereas Sox10 is also expressed in other neural 
crest populations and Ets1 in cranial and vagal neural crest cells (Fig. 6E). Interestingly, analysis 
of putative binding motifs using JASPAR (Mathelier et al., 2014) revealed three previously 
unrecognized putative MafB binding sites within the Sox10E2 enhancer (Fig. 6F), adding to sites 
already described for Ets1, cMyb and SoxE factors (Betancur et al., 2010). To test the necessity 
  
of MafB sites to mediate reporter expression, we individually mutated each motif within the 
enhancer. Wild-type or mutant constructs driving GFP were electroporated onto of HH4 chicken 
embryos together with wild-type Sox10E2 driving mCherry as a control reporter. Mutation of 
binding motifs MafB(b) and MafB(c) resulted in reduced GFP expression in cardiac neural crest 
cells at HH12 (Fig. 7D-I). In contrast, mutation of binding motif MafB(a) showed no reduction in 
GFP expression (Fig. 7A-C). These results suggest that the MafB(b) and MafB(c) binding sites 
within Sox10E2 contribute to driving reporter expression in the migrating cardiac neural crest 
cells. Taken together with our loss-of-function results, this suggests that MafB is a critical input for 
Sox10E2-driven Sox10 expression in the cardiac neural crest. 
 
DISCUSSION 
The cardiac neural crest is a unique cell population with the ability to contribute to critical 
components of the cardiac outflow tract and other cardiovascular derivatives. Interposed between 
the cranial and trunk neural crest, cardiac crest cells have an inherently different developmental 
potential than other neural crest populations. To isolate a pure population of cardiac neural crest 
cells, we took advantage of the fact that different enhancers mediate expression of the same 
factor at different levels of the body axis. Whereas the enhancer NC1 drives expression of the 
FoxD3 gene in the cranial neural crest, the enhancer NC2 mediates FoxD3 expression in the 
cardiac and trunk neural crest (Simões-Costa et al., 2012). A similar situation has been described 
for another neural crest gene, Sox10, which has separate cranial and trunk enhancers. However, 
the caudal limit of the cranial FoxD3 enhancer is above the ear, whereas the Sox10 cranial 
enhancer, Sox10E2, mediates expression in both the cranial and the post-otic region. Here we 
show that both FoxD3 NC2 and Sox10E2 enhancers are active in the cardiac neural crest; 
indeed, the region of overlap in the expression mediated by the “cranial” Sox10 enhancer and the 
“trunk” FoxD3 enhancer, defines the location of the cardiac neural crest.  
To gain insight into the molecular basis of the differences between cardiac and other 
neural crest populations, we performed genome-wide transcriptional profiling of a pure population 
  
of early migrating cardiac neural crest cells, using a neural crest specific enhancer. Our 
transcriptome analysis has led to discovery of numerous genes, including transcription factors 
and signaling molecules that are enriched in the cardiac neural crest and may imbue these cells 
with their unique properties. The results suggest that the cardiac neural crest has an overall 
transcriptional signature that is highly reminiscent of the cranial neural crest, with genes like Ets1 
shared between the two populations. Perhaps the fact that the “cranial” Sox10E2 enhancer drives 
expression in the cardiac neural crest partially explains the overlap between cranial and cardiac 
neural crest genes. While Ets1 is cranial/vagal specific, other critical neural crest genes like 
Sox10 and FoxD3 are expressed in all neural crest populations along the body axis.  
In addition to shared gene expression, there are also important transcriptional and 
signaling differences between the cardiac and other neural crest populations. For example, we 
found several transcription factors, including MafB and Krox20, selectively expressed in migrating 
cardiac crest cells but absent from other neural crest populations. Similarly, the receptor Ret was 
highly enriched in this cell population. These findings are consistent with previous reports of Ret in 
the vagal crest, which overlaps with cardiac neural crest (Natarajan et al., 2002). In the hindbrain, 
MafB and Krox20 have been well-studied and both are critical for normal patterning of the 
rhombomeres (Frohman et al., 1993; McKay et al., 1994; Schneider-Maunoury et al., 1993; 
Seitanidou et al., 1997). However, their expression and role in the cardiac neural crest has not 
been explored. Recently, Odelin et al. reported that Krox20-expressing neural crest cells populate 
the aortic valve in mice and that loss of Krox20 results in abnormal hypertrophic valves (Odelin et 
al., 2017). Although no heart defects have been reported in Kreisler mutant mice which are 
hypomorphic for MafB (Eichmann et al., 1997), the glossopharyngeal ganglion and nerve and the 
abducens nerve, which are the derivatives of neural crest cells from rhombomeres 5 or 6, are 
absent (McKay et al., 1994). 
Our functional studies show that MafB is important during cardiac neural crest 
development and likely to be a critical component of a cardiac specific gene regulatory subcircuit. 
After MafB knockdown, we observed a reduction of Sox10, Krox20, and MafB itself. We propose 
that MafB expression in the cardiac neural crest is derived from initial expression in rhombomeres 
  
5/6, then maintained during cardiac neural crest migration by positive autoregulation. Such 
autoregulation has previously been observed in hindbrain (Giudicelli et al., 2003). A similar 
autoregulation has been proposed for expression of Krox20 in rhombomere 5 and the 
rhombomere 5-derived neural crest cells. The model has two steps: initial Krox20 expression is 
activated in rhombomere 5 by hindbrain initiator elements; this is followed by maintenance of 
Krox20 expression in the neural crest by cis-acting enhancer elements activated by Krox20 itself 
and Sox10 (Ghislain et al., 2003). Although transcriptional regulation of MafB in the cardiac neural 
crest remains unexamined, given their co-expression in this cell population and the fact that loss 
of MafB causes reduced Krox20 expression, it will be interesting to test if there is cross-regulation, 
direct or indirect, between MafB and Krox20. 
Our results reveal a new role for MafB in regulating Sox10 expression. The Sox10E2 
enhancer drives specific expression in the cranial/vagal neural crest and the otic vesicle. Here we 
confirmed that the enhancer is also active in the cardiac neural crest cells and that it contains 
three putative MafB binding sites. Mutational analysis further revealed that removal of sites 
MafB(b) or MafB(c) reduces Sox10E2 reporter activity. This suggests that MafB may be a direct 
input into the expression of Sox10 gene. Previously, Ets1 has been shown to directly regulate this 
same Sox10E2 enhancer (Betancur et al., 2010). As MafB has been shown to interact with Ets1 in 
the hematopoietic system (Sieweke et al., 1996), we speculate that MafB and Ets1 may function 
in a transcriptional complex to directly activate Sox10E2 in the cardiac neural crest population 
(Fig. 6G).  
Previous loss of function studies in mouse (Gao et al., 2010; Ye et al., 2009) and Xenopus 
(Nie and Bronner, 2015) have shown that Ets1 plays an important role in cardiovascular 
development. Although Ets1 is expressed in both the cranial and cardiac neural crest, its loss of 
function appears to have a primary effect on the cardiac neural crest. For example, a mutation in 
the human Ets1 gene (Grossfeld et al., 2004) results in Jacobsen syndrome, characterized by 
septation defects that are reminiscent of cardiac neural crest ablation in the chick. By contrast, 
craniofacial defects in these patients are absent or minor. Similarly, Ets1 knockout mice have 
large membranous interventricular septal defects in the absence of other structural heart defects 
  
(Ye et al., 2009). This may suggest that the primary role of Ets1 may be in the cardiac neural 
crest. It is intriguing to speculate that MafB may have a role in conferring a “cardiac” identity onto 
Ets1-expressing neural crest cells. If so, addition of MafB may be sufficient to confer a cardiac 
crest identify onto other neural crest populations differentiated from ES and/or iPS cells, thus 
leading to a better understanding of the etiology of cardiac-crest related defects. 
Taken together, we propose that MafB is part of a gene regulatory subcircuit that is unique 
to the cardiac neural crest (Fig. 6G). Together with previous evidence suggesting a critical role for 
Ets1, we propose that MafB and Ets1 may work together in the cardiac neural crest to activate 
important neural crest genes like Sox10. MafB appears to be upstream of Sox10 and Krox20 and 
to positively autoregulate its expression. Future experiments testing the role of other cardiac 
specific transcription factors hold the promise of further elaborating this cardiac neural crest 
specific gene regulatory circuit. 
 
MATERIALS AND METHODS 
Embryos and electroporation 
Fertilized chicken eggs were obtained from commercial farms (U.S.A. or Japan) and 
incubated at 37°C to the desired HH stage (Hamburger and Hamilton, 1951). Electroporations 
were performed ex ovo at stage HH4 as previously described (Sauka-Spengler and Barembaum, 
2008), using 5 pulses of 5.2V for 50 ms with 100 ms intervals. After electroporation, embryos were 
cultured at 37°C on albumin-coated dishes until HH12. DNA concentration in injected solutions 
was 1.5 µg/µL for plasmids encoding gRNAs or 2 µg/µL for all other plasmids. MOs were 
electroporated at 1-1.5 mM. 
Tissue dissociation and cell sorting 
Embryos electroporated with pTK(NC2:EGFP) (Simões-Costa et al., 2012) were 
incubated until stage HH12 and had tissue from the region between the otic vesicle and the 3rd 
somite dissected and dissociated with Accumax (Innovative Cell Technologies, Inc.). Dissociated 
cells were prepared for fluorescence activated sorting as previously described (Simões-Costa et 
  
al., 2014). GFP+ and GFP- cells were sorted using the BD FACSAria Cell Sorter (BD 
Biosciences). 
RNA sequencing and analysis 
RNA was extracted from the sorted cells with RNAqueous-Micro Kit (Ambion) and libraries 
were prepared with the Ovation RNA-Seq System V2 (NuGEN). Three biological replicates of 
GFP+ and GFP- cells, each one pooled from several embryos, were sequenced on the Illumina 
HiSeq2500 platform. The sequenced reads were mapped to the chicken genome (galGal5) using 
HISAT2 (Kim et al., 2015) and read counts per gene were calculated using featureCounts (Liao et 
al., 2014). Differential gene expression analysis was performed using DESeq2 (Love et al., 2014) 
and genes with adjusted p-value below 0.05 were considered to be differentially expressed. 
Protein classification analysis was performed using PANTHER (Thomas, et al., 2003). Functional 
annotation clustering was performed using DAVID and human genome annotations (Huang et al., 
2009). 
cDNA synthesis 
Total RNA was extracted with RNAqueous Kit (Ambion) from HH11-12 embryos and 
cDNA was synthesized with SuperScript III (Invitrogen). Gene fragments were amplified with 
Phusion High Fidelity PCR Kit (New England BioLabs). 
In situ hybridization 
RNA probes were synthesized with DIG-RNA labeling mix (Roche) and SP6 promoter or 
T7 RNA polymerases (Promega). Templates for Cxcr4, Nrip and MafB probes were amplified with 
primers listed in Supplemental Table 3 and cloned into pGEM-T (Promega) or TOPO TA 
(Invitrogen) vectors. Two templates for MafB were used: the entire coding sequence, amplified 
with MafB-Fw1 and MafB-Rv1 and used for WT or MO-electroporated embryos, or the N-terminal 
coding region (1-194 aa), amplified with MafB-Fw1 and MafB-Rv2 and used for embryos 
electroporated with MafB dominant negative constructs. Templates for Dlx5, Msx1, Ret, TFAP2A 
and Ets1 were EST clones (BBSRC ChickEST Database) and templates for LBH, LTK, Mef2C, 
  
RXRG, Slit1, Snail2, Sox10 and TFAP2B were previously described (Giudicelli et al., 2001; 
Simões-Costa et al., 2014). Whole mount in situ hybridization was performed as previously 
described (Acloque et al., 2008). Fluorescence in situ hybridization was performed with the TSA 
Plus Cyanine 3/Fluorescein Kit (PerkinElmer). 
Immunostaining 
Embryos were fixed with 4% paraformaldehyde, washed three times with 0.2% Triton 
X-100 and 0.1% DMSO in PBS and blocked with 10% donkey serum diluted in the same solution. 
The following primary antibodies were used: anti-HNK-1 (DSHB Cat# 3H5, RRID:AB_2314644; 
1:10), anti-GFP (Thermo Fisher Scientific Cat# A-11122, RRID:AB_221569 or Abcam Cat# 
ab6673, RRID:AB_305643; 1: 100 or 1:1000, respectively), anti-mCherry (MBL International Cat# 
PM005, RRID:AB_591279; 1:1000). The secondary antibodies were donkey anti-rabbit IgG, 
donkey anti-mouse IgG or goat anti-mouse IgM conjugated with Alexa Fluor 488/594 (Molecular 
Probes Cat# A-11055, RRID:AB_142672; Cat# A-21207, RRID:AB_141637; Cat# A-21042, 
RRID:AB_141357; Cat# A-21044, RRID:AB_141424; 1:2000). DAPI was used for nuclei 
counterstaining. 
Histology 
Stained embryos were cryoprotected with sequential immersion in 5% and 15% sucrose in 
PBS until equilibrated, followed by infiltration with 7.5% gelatin for at least 3 hours at 37°C. The 
embryos were embedded into gelatin and frozen in liquid nitrogen. Sections of 10-20 m were 
obtained using a Microm cryostat (HM550). After sectioning and prior to mounting, gelatin was 
removed from slides by soaking in PBS at 37°C for 15 min. 
Loss-of-function studies 
MafB and standard control MOs were purchased from Gene Tools. To create the empty 
vector pCI-FLAG-H2B-RFP, the oligos FLAG-Fw and FLAG-Rv (Supplemental Table 3) were 
annealed and inserted into pCI-IRES-H2B-RFP digested with XhoI and SphI. To create 
pCI-(FLAG-MafBN-H2B-RFP), MafBN was amplified with the primers MafB-Fw2 and 
  
MafB-Rv3 (Supplemental Table 3) and cloned into pCI-FLAG-IRES-H2B-RFP. To create 
pCI-(FLAG-MafBN-EnR-H2B-RFP), the Engrailed repressor domain was inserted into 
pCI-FLAG-MafBN-H2B-RFP after removal of the stop codon of MafBN. CRISPR-mediated loss 
of MafB was performed using pCAG(NLS-Cas9-NLS) and cU6.3 plasmids to drive expression of 
control or targeted gRNA, co-electroporated with pCI(H2B-RFP) to ensure efficient transfection of 
the embryos analyzed (Gandhi et al., 2017). The genomic locus of MafB was obtained from 
UCSC genome browser (Kent et al., 2002). MafB.1.gRNA 
(5’-GCCCGCAAGACAGCGATGGC-3’) and MafB.2.gRNA 
(5’-GGAGCCGATGAGGGCTTCGA-3’) were designed using the CRISPR-design tool available at 
http://crispr.mit.edu. For effects on the Sox10E2 enhancer, knock-down reagents were 
co-electroporated with pTK(Sox10E2:EGFP) (Betancur et al., 2010). 
Binding motif analysis 
MafB binding motifs were predicted using JASPAR database (Mathelier et al., 2014). 
Mutated Sox10E2 fragments were created with the KOD Kit (Takara), using primers for amplifying 
Sox10E2 combined with primers designed to introduce MafB(a), MafB(b), or MafB(c) 
(Supplemental Table 3) mutations, and cloned into Kpnl/Xhol sites of pTK-EGFP (Uchikawa et al., 
2003). 
 
ACKNOWLEDGEMENTS 
We thank Dr. Patrick Charnay for the chicken Krox20 probe and the Caltech Flow 
Cytometry and Genomics Facilities for technical support. This work was supported by Toyobo 
Biotechnology Foundation postdoctoral fellowship and Japan Society for the Promotion of 
Science KAKENHI JP16K18551 to STM, National Institutes of Health R01DE024157 and 
RO1HL140587 to MEB and a postdoctoral fellowship from the Curci Foundation to FMV. 
 
 
  
Supplemental Figure 1. Neural crest expression of selected genes enriched in post-otic 
NC2+ sorted cells. (A-F) Transverse sections of HH12/13 embryos stained with in situ 
hybridization showing expression in the migratory cardiac neural crest, identified with HNK-1 
immunostaining in (D-F). 
Supplemental Figure 2. MafB is specifically expressed in the hindbrain and cardiac neural 
crest. (A-C) In situ hybridization showing MafB expression in HH10 (A) and HH13 (B-C) embryos; 
(C) is a transverse section of the embryo shown in (B). 
Supplemental Figure 3. MafB MO blocks translation of MafB transcript. (A) Diagram 
showing the reporter construct designed to test activity of MafB MO, where the MafB 5’ 
untranslated region (UTR) and partial coding sequence, containing the MO target, were fused in 
frame with the RFP coding sequence. (B) Diagram showing double-sided co-electroporation of 
the reporter construct with MafB MO on the right side or a control MO on the left side. (C-E) 
Immunostaining showing successful delivery of FITC-tagged MOs on both sides (C) and specific 
loss of RFP reporter on MafB-depleted side. White dashed lines indicate the midline. 
Supplemental Figure 4. Effects of MafB loss on expression of neural crest markers. (A) In 
situ hybridization for Sox10 after MAFB MO electroporation showing examples of none, mild, 
strong or severe phenotypes. Gray and black arrowheads point to wild-type and MafB-depleted 
cardiac neural crest streams, respectively. (B) Barplots for the qualitative classification based on 
severity of the phenotype after electroporation of control or MafB loss-of-function reagents, as 
assessed by immunostaining with HNK-1 or in situ hybridization for Sox10, MafB, Krox20 or Ets1. 
n: number of embryos analyzed per condition. 
Supplemental Figure 5. MafBN-EnR causes loss of cardiac neural crest markers. (A-F) In 
situ hybridization for Sox10 (A-B), MafB (C-D) or Krox20 (E-F) in HH12 embryos after empty vetor 
(A,C,E) or MAFBN-EnR (B,D,F) electroporation at HH4, showing down-regulation of these 
markers in MafB-depleted cardiac neural streams. White, gray and black arrowheads point to 
wild-type, control and MafB-depleted cardiac neural crest streams, respectively. 
  
Supplemental Figure 6. MafB is not required for NC2 enhancer activity. (A) NC2-driven 
mCherry expression in HH12 embryos electroporated with NC2:mCherry on both sides together 
with control or MafB gRNAs on either side of the embryo, showing no reduction in NC2-driven 
expression after loss of MafB. Gray and yellow arrowheads point to control and MafB-depleted 
cardiac neural crest streams, respectively. The dashed white line indicate the midline. 
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Figure 1. RNA-seq analysis of the migrating cardiac neural crest. (A-B) Immunostaining 
showing GFP reporter expression at stage HH12 (A) in the post-otic region (B), after 
electroporation at stage HH4; (B) is a higher magnification picture of the embryo shown in (A), the 
dashed line delimits the axial level isolated for cell sorting. White arrows point to otic vesicle. (C) 
Immunostaining with HNK-1 of a transverse section confirmed the neural crest identity of 
GFP-positive cells in the post-otic region (arrowheads). (D) Plot showing fluorescence intensities 
of cells pooled to form the GFP-positive (blue) and GFP-negative (red) sorted populations. (E) 
Volcano plot showing differential expression data obtained after comparison of RNA-seq data 
obtained from GFP+ and GFP- cell populations. (F) Venn diagrams showing overlap of 
upregulated gene lists obtained for cardiac or cranial (Simões-Costa et al., 2014) neural crest cell 
  
populations. (G) Bar plots showing top hits for annotated genes enriched in the cardiac neural 
crest, after excluding genes also present in cranial neural crest cells. (H) Classification of proteins 
encoded by genes upregulated in the cardiac neural crest. (I) GO terms highly associated with 
cardiac neural crest genes. 
Figure 2. Spatial expression pattern of genes enriched in the cardiac neural crest. (A,C-O) 
In situ hybridization of HH12/13 embryos showing expression in cardiac neural crest streams as 
seen from dorsal views of whole mount embryos. (B) Double fluorescence in situ hybridization 
showing overlap between MafB and Krox20 expression in the cardiac neural crest and 
rhombomere 5 (r5), but not 3 (r3) and 6 (r6), positive for either Krox20 or MafB alone, respectively. 
Figure 3. MafB is required in the cardiac neural crest. (A) Diagrams showing position of the 
MO target in the MafB transcript and protein domains in MafB wild-type, acidic-domain truncated 
(MafBN; 194-312 aa) and Engrailed-fused (MafBN-EnR) constructs. (B) Diagram showing 
unilateral ex ovo electroporation of HH4 embryos. (C-L) Immunostaining of HH12 embryos for 
FITC, RFP or HNK-1 after electroporation of control MO (C,D), MafB MO (E-F), H2B-RFP (G,H), 
MafBN (I,J) or MafBN-EnR (K,L) showing normal cardiac neural crest streams in embryos 
transfected with control reagents (D,H) and reduced cardiac neural crest streams after 
transfection of MafB loss-of-reagents (F,J,L) when compared to contralateral controls (left side). 
White, gray and yellow arrowheads point to wild-type, control and MafB-depleted cardiac neural 
crest streams, respectively. Dashed white lines indicate the midline. 
Figure 4. MafB is required for expression of cardiac neural crest markers. (A) Diagram 
showing positions of targets of two MafB gRNAs within the MafB gene. (B-M) In situ hybridization 
for Sox10 (B-D), MafB (E-G), Krox20 (H-J) or Ets1 (K-M) of HH12 embryos unilaterally 
electroporated with control MO (B,E,H,K) or MafB MO (C,F,I,L), or bilaterally electroporated with 
control and MafB gRNAs (D,G,J,M) showing reduced expression after loss of MafB. White, gray 
and black arrowheads point to wild-type, control and MafB-depleted cardiac neural crest streams, 
respectively. 
  
Figure 5. MafB is required for Sox10E2 enhancer activity. (A) Diagram showing double-sided 
electroporation of control and loss-of-function reagents onto the left and right sides of HH4 
embryos, respectively. (B-D) Immunostaining for GFP in HH12 embryos electroporated with 
Sox10E2:EGFP on both sides alone (B) or together with control or MafB loss-of-function (LOF) 
constructs on either side of the embryo (C,D), showing loss of Sox10E2-driven expression after 
loss of MafB. White, gray and yellow arrowheads point to wild-type, control and MafB depleted 
cardiac neural crest streams, respectively. Dashed white lines indicate the midline. 
Figure 6. A model for MafB function in the neural crest. (A-D) In situ hybridization showing 
expression of Sox10, Ets1, Krox20 and MafB in cranial, cardiac and trunk neural crest axial levels 
at stage HH12; blue, red and green arrowheads show expression in cranial, cardiac and trunk 
populations, respectively. (E) Diagram of the neural crest expression patterns of Sox10, Ets1, 
Krox20 and MafB, represented by separate gray bars: all genes are present in the cardiac 
population, whereas Ets1 is expressed in cranial cells and Sox10 is a marker for the neural crest 
along the entire neural axis. (F) Diagram showing the position of transcription factor binding sites 
(colored boxes) in the Sox10E2 sequence, depicting three putative MafB sites (a, b and c) 
(orange). (G) A model for Sox10E2 activation mediated by binding of MafB and Ets1 to adjacent 
sites in the Sox10E2 enhancer. 
Figure 7. MafB(b) and MafB(c) are required for MafB activation of the Sox10E2 enhancer 
(E2). (A-I) Immunostaining for mCherry (magenta) and GFP (green) in HH12 embryos 
electroporated at HH4 to express wild-type Sox10E2-driven GFP on the left side and 
Sox10E2-MafB(a) (A-C), Sox10E2-MafB(b) (D-F) or Sox10E2-MafB(c) (G-I) on the right side, 
showing reduced reporter expression driven by Sox10E2-MafB(b) (E-F) and Sox10E2-MafB(c) 
(H-I) constructs. Gray and yellow arrowheads point to cardiac neural crest stream reporter 
expression driven by control and mutated constructs, respectively. Dashed white lines indicate 
the midline. ov: otic vesicle. 
 
 
  
HIGHLIGHTS 
- We describe the transcriptome of early migrating cardiac neural crest cells. 
- We show that the transcription factor MafB is required in migrating cardiac neural crest 
cells. 
- We characterize two biologically relevant MafB binding sites within the Sox10 enhancer 
Sox10E2. 
 
  
 
  
 
  
 
 
  
 
  
 
 
 
 
  
 
